肥胖阻塞性睡眠呼吸暂停患者的上颌下颌前移术:一项Meta分析
该Meta分析检索多个数据库至2024年4月3日,纳入14项研究共143例肥胖(BMI≥30 kg/m2)阻塞性睡眠呼吸暂停患者,评估上颌下颌前移术的疗效。结果显示呼吸暂停低通气指数、最低血氧饱和度和Epworth嗜睡量表均显著改善,手术治愈率39.2%、成功率85.6%,3级肥胖患者AHI百分比降低幅度显著大于1级和2级肥胖患者。
要点
- 肥胖OSA患者行上颌下颌前移术后AHI降低57.3、LSAT升高14.1%、ESS降低9.4,均显著改善。
- 手术治愈率为39.2%(95%CI 20.3-60.0),手术成功率为85.6%(95%CI 77.8-91.5)。
- 3级肥胖患者AHI百分比降低92.9%,显著大于1级肥胖的85.5%和2级肥胖的83.6%。
核心结论
- 上颌下颌前移术可显著改善肥胖OSA患者的主观和客观结局,效果与总体人群相当。
- 平均BMI最高的研究中手术成功率仍高于80%。
- 3级肥胖患者基于AHI百分比降低的获益显著大于1级和2级肥胖患者。
研究设计与样本
- 系统综述与Meta分析,检索Scopus、PubMed、CINAHL和The COCHRANE Library,检索时间从建库至2024年4月3日。
- 共纳入14项研究、143例受试者,平均年龄44.3岁(范围17-69),男性占80.2%(95%CI 72.5-86.5)。
- 平均BMI为35.3(95%CI 33.1-37.5),上颌下颌前移术后平均随访时间13.7个月(95%CI 10.1-17.3)。
- 证据等级为1级。
主要发现
- 呼吸暂停低通气指数降低57.3(95%CI -71.5至-43.2,p<0.0001)。
- 最低血氧饱和度升高14.1%(95%CI 9.9至18.3,p<0.0001)。
- Epworth嗜睡量表评分降低9.4(95%CI -13.5至-5.2,p<0.0001)。
- 手术治愈率为39.2%(95%CI 20.3-60.0),手术成功率为85.6%(95%CI 77.8-91.5)。
- 3级肥胖AHI百分比降低92.9%,1级肥胖降低85.5%,2级肥胖降低83.6%;1级与3级比较p=0.0012,2级与3级比较p=0.015。
关键数值与推荐
- 肥胖定义为体重指数≥30 kg/m2。
- 手术治愈率39.2%(95%CI 20.3-60.0),手术成功率85.6%(95%CI 77.8-91.5)。
- 3级肥胖AHI百分比降低92.9%,1级肥胖降低85.5%,2级肥胖降低83.6%;1级与3级比较p=0.0012,2级与3级比较p=0.015。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To systematically review polysomnographic and cephalometric data in obstructive sleep apnea (OSA) patients with obesity (body mass index [BMI] ≥30 kg/m2) treated with maxillomandibular advancement (MMA). DATA SOURCES: Scopus, PubMed, CINAHL, and The COCHRANE Library. REVIEW METHODS: A search was performed from inception until April 3, 2024, in each database. RESULTS: A total of 14 studies (143 subjects) were included. The mean age was 44.3 years (range: 17-69), 80.2% males (95% CI: 72.5-86.5), mean BMI of 35.3 (95% CI: 33.1-37.5), and mean duration to follow-up post-MMA was 13.7 months (95% CI: 10.1-17.3). All objective outcomes improved significantly; overall, apnea-hypopnea index (AHI) decreased by -57.3 ([95% CI: -71.5 to -43.2], p < 0.0001) lowest oxygen saturation (LSAT) increased by 14.1% ([95% CI: 9.9 to 18.3], p < 0.0001), and Epworth Sleepiness Scale (ESS) decreased by -9.4 ([95% CI: -13.5 to -5.2], p < 0.0001). Surgical cure was 39.2% (95% CI: 20.3-60.0), and surgical success was 85.6% (95% CI: 77.8-91.5). Comparing percent reduction in class 3 obesity (-92.9%) as compared to class 1 (-85.5%) and class 2 (-83.6%) exhibited a significant difference (1 vs 3 p = 0.0012, 2 vs 3 p = 0.015). CONCLUSIONS: Our findings suggest that MMA significantly improves subjective and objective outcomes in OSA amongst patients with obesity with results comparable to the overall population. Success rates remained above 80% in studies with the highest mean BMI. In addition, patients with class 3 obesity yielded a significantly increased benefit based on percent reduction in AHI compared with class 1 and 2. LEVEL OF EVIDENCE: 1 Laryngoscope, 135:507-516, 2025.
引用
- Diemer TJ, Nanu DP, Nguyen SA, et al. Maxillomandibular Advancement for Obstructive Sleep Apnea in Patients With Obesity: A Meta-Analysis. Laryngoscope. 2024. PMID: 39264209. doi:10.1002/lary.31751
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。